新辅助化疗：肌肉浸润性膀胱癌的一种新治疗模式。 - Suppr

Suppr

超能文献

Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer.

作者信息

Herr Harry W

出版信息

Eur Urol. 2009 Feb;55(2):303-5; discussion 305-6. doi: 10.1016/j.eururo.2008.10.033. Epub 2008 Nov 4.

DOI:10.1016/j.eururo.2008.10.033

PMID:18995950

Abstract

摘要

相似文献

Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer.新辅助化疗：肌肉浸润性膀胱癌的一种新治疗模式。

Eur Urol. 2009 Feb;55(2):303-5; discussion 305-6. doi: 10.1016/j.eururo.2008.10.033. Epub 2008 Nov 4.

Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer.新辅助化疗在肌肉浸润性膀胱癌治疗中的应用

Semin Urol Oncol. 2001 Aug;19(3):180-5.

Neoadjuvant chemotherapy in patients with invasive bladder cancer.浸润性膀胱癌患者的新辅助化疗

Urol Clin North Am. 2005 May;32(2):231-7. doi: 10.1016/j.ucl.2005.03.001.

Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy.基线肾功能状况限制了患者接受浸润性膀胱癌围手术期化疗的资格，且对根治性膀胱切除术的影响最小。

Urology. 2011 Jan;77(1):160-5. doi: 10.1016/j.urology.2010.03.091. Epub 2010 Aug 14.

Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.浸润性膀胱癌患者根治性膀胱切除术后辅助铂类联合化疗的预后意义。

Int J Urol. 2008 Apr;15(4):314-8. doi: 10.1111/j.1442-2042.2008.02000.x.

Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.新辅助化疗尚未成为肌层浸润性膀胱癌的标准治疗方法。

J Clin Oncol. 2001 Sep 15;19(18 Suppl):21S-26S.

Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.肌层浸润性膀胱癌的围手术期化疗可提高生存率和/或作为膀胱保留策略。

Semin Oncol. 2007 Apr;34(2):122-8. doi: 10.1053/j.seminoncol.2006.12.006.

Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.浸润性膀胱癌的新辅助化疗和辅助化疗

Semin Oncol. 1995 Dec;22(6):625-32.

Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.新辅助化疗与辅助化疗及膀胱切除术在肌层浸润性膀胱癌治疗中的整合

BJU Int. 2008 Nov;102(9 Pt B):1339-44. doi: 10.1111/j.1464-410X.2008.07980.x.

Editorial comment.编者按。

Urology. 2011 Jan;77(1):165-6. doi: 10.1016/j.urology.2010.05.008.

引用本文的文献

Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea.韩国多中心研究：机器人辅助根治性膀胱切除术治疗尿路上皮癌的肿瘤学结果和复发预测因素。

J Korean Med Sci. 2017 Oct;32(10):1662-1668. doi: 10.3346/jkms.2017.32.10.1662.

Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience.新辅助化疗后行部分膀胱切除术：纪念斯隆凯特琳癌症中心的当代经验

Int Sch Res Notices. 2014 Nov 13;2014:702653. doi: 10.1155/2014/702653. eCollection 2014.

Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion.肌肉浸润性膀胱癌的新辅助化疗和辅助化疗：开始和完成的可能性。

Indian J Urol. 2012 Oct;28(4):424-6. doi: 10.4103/0970-1591.105756.

Perioperative chemotherapy for muscle-invasive bladder cancer.肌肉浸润性膀胱癌的围手术期化疗

Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S223-7. doi: 10.5489/cuaj.1202.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验